上海惠诚生物2010年至今专注于食品检测方面的标准品,优势品牌系列:
药物: TRC LGC USP LKT Focus
植提标准品: Extrasynthese PhytoLab Chromadex CaroteNature
糖类: Elicityl TDB Ludger Megazyme Glycarbo
脂类: Nu-Chek Larodan Avanti Matreya
其他: TCI ERM Wako Jackson Cayman laysan
手机微信:17715331663 QQ:2303607288
Description
ARRY-162 is an orally bioavailable non-competitive inhibitor of MEK1/2 and pERK that shows anticancer activity. Inhibition of MEK inhibits downstream signaling by IL-1, IL-6, and TNF, cytokines that act as growth factors. ARRY-162 inhibits proliferation in melanoma, non-small-cell lung cancer, head/neck cancer, and pancreatic cancer models. This compound is currently in clinical trials.
|
|||||||||||||||||||
Specifications | |||||||||||||||||||
|